Esben Iversen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 18

Top Topics

Patients Undergoing

Machine Learning

Chronic Kidney Disease

Top Venues

Basic & clinical pharmacology & toxicology

Diabetes, obesity & metabolism

British journal of clinical pharmacology

Diabetes spectrum : a publication of the American Diabetes Association

This page only lists publications with an associated author ORCID identifier.

Publications

Louise Westberg Strejby Christensen, Esben Iversen, Aino Leegaard Andersen, Anne Byriel Walls, Line Jee Hartmann Rasmussen, Ove Andersen, Thomas Kallemose, Morten Baltzer Houlind
A characterization of patients with low soluble urokinase plasminogen activator receptor who died within 90 days of hospital discharge. Basic & clinical pharmacology & toxicology 135 (3) (2024)
Esben Iversen, Katrine McLain Christensen, Anne Byriel Walls, Mie Klessen Eickhoff, Bernt Johan von Scholten, Marie Frimodt-Møller, Tine Willum Hansen, Stephen C Bain, Ellen Burgess, Viktor Rotbain Curovic, Morten Baltzer Houlind
Performance of new and panel CKD-EPI equations in European adults with type 2 diabetes. Diabetes, obesity & metabolism (2024)
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology (2024)
Esben Iversen, Katrine McLain Christensen, Anne Byriel Walls, Mie Klessen Eickhoff, Bernt Johan von Scholten, Marie Frimodt-Møller, Tine Willum Hansen, Stephen C Bain, Ellen Burgess, Viktor Rotbain Curovic, Morten Baltzer Houlind
Performance of new and panel CKD-EPI equations in European adults with type 2 diabetes. Diabetes, obesity & metabolism 26 (6) (2024)
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology 134 (5) (2024)
Matthew Verdone, Jonathan Bauman, Esben Iversen, Rifka Schulman-Rosenbaum, Anthony C Antonacci, Sabatino Leffe, Joseph Simpson, Yael Tobi Harris, Joseph Marino
Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis. Diabetes spectrum : a publication of the American Diabetes Association 37 (2) (2024)
Matthew Verdone, Jonathan Bauman, Esben Iversen, Rifka Schulman-Rosenbaum, Anthony C Antonacci, Sabatino Leffe, Joseph Simpson, Yael Tobi Harris, Joseph Marino
Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis. Diabetes spectrum : a publication of the American Diabetes Association 37 (2) (2024)
Louise Westberg Strejby Christensen, Esben Iversen, Aino Leegaard Andersen, Anne Byriel Walls, Line Jee Hartmann Rasmussen, Ove Andersen, Thomas Kallemose, Morten Baltzer Houlind
A characterization of patients with low soluble urokinase plasminogen activator receptor who died within 90 days of hospital discharge. Basic & clinical pharmacology & toxicology (2024)
Esben Iversen, Katrine McLain Christensen, Anne Byriel Walls, Mie Klessen Eickhoff, Bernt Johan von Scholten, Marie Frimodt-Møller, Tine Willum Hansen, Stephen C Bain, Ellen Burgess, Viktor Rotbain Curovic, Morten Baltzer Houlind
Performance of new and panel CKD-EPI equations in European adults with type 2 diabetes. Diabetes, obesity & metabolism 26 (6) (2024)
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology 134 (5) (2024)
Esben Iversen, Morten Baltzer Houlind, Trine Meldgaard Lund, Morten Baltzer Houlind
Comment on Delanaye et al: Future perspectives regarding kidney function estimates and dose adjustments. British journal of clinical pharmacology 88 (6) (2022)
Tanja Stenholdt Andersen, Mia Nimb Gemmer, Hayley Rose Constance Sejberg, Lillian Mørch Jørgensen, Thomas Kallemose, Ove Andersen, Esben Iversen, Morten Baltzer Houlind
Medicines Reconciliation in the Emergency Department: Important Prescribing Discrepancies between the Shared Medication Record and Patients' Actual Use of Medication. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Esben Iversen, Thomas Kallemose, Morten Baltzer Houlind, Anne Kathrine Bengaard, Jan Olof Nehlin, Line Jee Hartmann Rasmussen, Haakon Sandholdt, Juliette Tavenier, Bo Feldt-Rasmussen, Ove Andersen, Jesper Eugen-Olsen, Morten Baltzer Houlind
Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease. Clinical kidney journal 15 (8) (2022)
Morten Baltzer Houlind, Esben Iversen, Baker Nawfal Jawad, Thomas Kallemose, Morten Baltzer Houlind
Machine Learning to Identify Patients at Risk of Inappropriate Dosing for Renal Risk Medications: A Critical Comment on Kaas-Hansen et al [Letter]. Clinical epidemiology 14 (2022)
Esben Iversen, Anne Byriel Walls, Annamarie Petersen, Pia Søe Jensen, Thomas Kallemose, Aino Andersen, Rikke Lundsgaard Nielsen, Anne Kathrine Bengaard, Helle Gybel Juul-Larsen, Olivia Bornaes, Morten Damgaard, Ove Andersen, Juliette Tavenier, Morten Baltzer Houlind
Estimated glomerular filtration rate based on creatinine, cystatin C, beta-trace protein, and beta-2 microglobulin in patients undergoing non-traumatic lower extremity amputation. British journal of clinical pharmacology (2022)
Esben Iversen, Lene Boesby, Ditte Hansen, Morten Baltzer Houlind
Comparison of 24-hour urinary creatinine clearance and estimated glomerular filtration rate based on a panel of filtration markers in patients with chronic kidney disease. Pharmacology research & perspectives 10 (5) (2022)
Esben Iversen, Anne Byriel Walls, Annamarie Petersen, Pia Søe Jensen, Thomas Kallemose, Aino Andersen, Rikke Lundsgaard Nielsen, Anne Kathrine Bengaard, Helle Gybel Juul-Larsen, Olivia Bornaes, Morten Damgaard, Ove Andersen, Juliette Tavenier, Morten Baltzer Houlind
Estimated glomerular filtration rate based on creatinine, cystatin C, β-trace protein and β2 microglobulin in patients undergoing nontraumatic lower extremity amputation. British journal of clinical pharmacology (2022)
Morten Baltzer Houlind, Esben Iversen, Aino Leegaard Andersen, Helle Gybel Juul-Larsen, Nicholas Carlson, Ove Andersen, Morten Baltzer Houlind
Further perspectives on statin use in patients with chronic kidney disease. Basic & clinical pharmacology & toxicology 131 (5) (2022)